Pharmacists in Chinook, MT Accepting Medicare

3 Pharmacists found. Showing 1 - 3

Mr. Kelcey John Diemert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 96 3rd Street, Chinook, MT 59523 Phone: 406-357-3333    Fax: 406-357-3336

Angela Jean Billmayer, PHARM.D. Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 300 Indiana Street, Chinook, MT 59523 Phone: 406-357-3333

Mrs. Nancy Diemert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 96 3rd Street, Chinook, MT 59523 Phone: 406-357-3333    Fax: 406-357-3336

News Archive

CytRx granted U.S. Patent for bafetinib

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the granting by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent 7,728,131 for oncology drug candidate bafetinib, encompassing claims related to bafetinib's pharmaceutical compound and composition in all indications, as well as for use in methods for treating acute and chronic myelogenous leukemia and acute lymphoblastic leukemia.

One-third of Americans experience Hospital Acquired Infection: Xenex Healthcare survey

Nearly one-third of Americans have experienced a Hospital Acquired Infection (HAI) or have a friend or relative who contracted one, according to a new survey from Xenex Healthcare. HAIs (such as C. diff, MRSA, staph infections and pneumonia) are the fourth leading cause of death in the U.S., according to the Centers for Disease Control and Prevention, and while hospitals have stepped up efforts to prevent these deadly infections, more needs to be done.

Midatech raises £6.3M through private investment round

Midatech Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, announced today it has raised £6.3 million through a private investment round.

Researchers reveal specific enzyme responsible for sensing energy source that fuels growth of cancer cells

An international research team formed by a University of Cincinnati cancer researcher has shown for the first time that a specific enzyme is responsible for sensing the available supply of GTP, an energy source that fuels the uncontrolled growth of cancer cells. The research underscores the enzyme's potential to become a therapeutic target for future cancer drugs.

Read more Medical News

› Verified 6 days ago